Please login to the form below

Not currently logged in

Boehringer and Novartis in the running for social media award

Firms are among those shortlisted at PM Society's Digital Awards

Twitter pharma hashtagBoehringer Ingelheim and Novartis are among the big pharma firms shortlisted for Social Media Pharma Company of the Year at next week's PM Society Digital Awards.

They will be competing against AbbVie, Bayer and Pfizer for the prize, whose finalists were determined as having the five most influential Twitter accounts.

This was done by Symplur Signals, which analysed online conversations in 2015 around the top 10 diseases with the highest mortality rates, in the process collecting 606 million healthcare tweets.

Boehringer and Novartis were the first two companies in the industry to join Twitter in 2008, with the following year proving something of a tipping point for the social network and its use by pharma.

The site has since become a mainstream tool for healthcare communications - despite occasional missteps and fears about using social media in a highly regulated environment.

The PM Society Digital Awards will take place in London on Wednesday 27 April

Article by
Dominic Tyer

21st April 2016

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

The truth is out there: Patients first
Patient centricity, patient focus, patients first – words that are on everyone’s lips these days. But what do they really mean? Where does the patient voice fit in? And what...
mHealth: The revolution will not be digital
Could mHealth, which has been growing exponentially in recent years, be the answer we have been looking for to address our population health challenge? Could mHealth save healthcare?...
Medical information in precision medicine
Global Medical Information Leader James Oughton reveals the top trends in medical information and precision medicine....